Latest news
Medicus Pharma targets Gorlin Syndrome with SkinJect - ICYMI - Proactive financial newsProactive financial news · Sat, 01 Aug 2026 18:01:32 GMTFDA Recommends Two-Year Follow-Up for Gorlin Syndrome Study - Stock TitanStock Titan · Mon, 27 Jul 2026 12:17:00 GMTMedicus Pharma receives FDA clearance to begin registrational SkinJect study for Gorlin syndrome - Proactive financial newsProactive financial news · Mon, 27 Jul 2026 09:34:00 GMTMedicus Pharma cleared by FDA for registrational Phase 2b trial in patients with Gorlin Syndrome - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTMedicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMT